Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

540.03
Delayed Data
As of Jul 27
 -1.82 / -0.34%
Today’s Change
299.73
Today|||52-Week Range
569.91
+31.63%
Year-to-Date

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 520.50, with a high estimate of 650.00 and a low estimate of 450.00. The median estimate represents a -3.62% decrease from the last price of 540.03.

Analyst Recommendations

The current consensus among 26 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.78
Sales
$888.1M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.32%
 
 
 
 
 
 
Growthannually 12.11%
 
 
 
 
 
 

Sales

Growthquarterly 2.12%
 
 
 
 
 
 
Growthannually 32.51%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account